TNF Pharmaceuticals Inc. (TNFA) Soars 8.18% on R&D Optimism

TNF Pharmaceuticals Inc. (TNFA) surged 8.18% in pre-market trading on August 12, 2025, marking a significant rise in its stock price.

Recent price prediction charts for TNF Pharmaceuticals Inc. (TNFA) indicate a potential -10% change over the next month, based on its high volatility and market trends. This forecast suggests that investors should closely monitor the stock's performance and consider the potential risks associated with short-term price fluctuations.

In addition to price predictions, TNF Pharmaceuticals Inc. has been in the spotlight for its ongoing research and development efforts in the pharmaceutical industry. The company's focus on innovative therapies and drug optimisation has garnered attention from investors and industry experts alike. The company's commitment to therapeutic drug monitoring and optimisation of drug levels is expected to drive future growth and enhance its market position.